GLOBUS MEDICAL INC (GMED) is a publicly traded company in the Unknown sector. Across all available filings, 26 corporate insiders have executed 375 transactions totaling $472.6M, demonstrating a bearish sentiment with -$472.4M in net insider flow. The most recent transaction on Jan 21, 2026 involved a transaction of 15,000 shares valued at $0.
No significant insider buying has been recorded for GMED in the recent period.
No significant insider selling has been recorded for GMED in the recent period.
Based on recent SEC filings, insider sentiment for GMED is bearish with an Insider Alignment Score of 0/100 and a net flow of -$472.4M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at GLOBUS MEDICAL INC (GMED) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 26 insiders are actively trading GMED stock, having executed 375 transactions in the past 90 days. The most active insider is David C. Paul (Executive), who has made 43 transactions totaling $244.8M.
Get notified when executives and directors at GMED file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 21, 2026 | D. Rhoads Ann | Executive | Award | 15,000 | $N/A | $0 | |
| Jan 21, 2026 | Lemaitre Dan | Executive | Award | 15,000 | $N/A | $0 | |
| Jan 21, 2026 | Andrew Douglas Robert | Executive | Award | 15,000 | $N/A | $0 | |
| Jan 21, 2026 | C. Paul David | Executive | Award | 100,000 | $N/A | $0 | |
| Jan 21, 2026 | Kline Kyle | Senior Vice President, CFO | Award | 30,000 | $N/A | $0 | C-Suite |
| Jan 21, 2026 | Huller Kelly | EVP, GC, Corporate Secretary | Award | 40,000 | $N/A | $0 | |
| Jan 21, 2026 | D. Davidar David | Executive | Award | 15,000 | $N/A | $0 | |
| Jan 21, 2026 | Wolterman Dan | Executive | Award | 15,000 | $N/A | $0 | |
| Jan 21, 2026 | A. Deford John | Executive | Award | 15,000 | $N/A | $0 | |
| Jan 8, 2026 | Norwalk Leslie V | Executive | Sale | 2,000 | $101.10 | $202.2K | |
| Jan 8, 2026 | Kline Kyle | Senior Vice President, CFO | Option Exercise | 3,594 | $N/A | $0 | C-Suite |
| Jan 8, 2026 | Kline Kyle | Senior Vice President, CFO | Sale | 3,594 | $101.10 | $363.4K | C-Suite |
| Jan 8, 2026 | Kline Kyle | Senior Vice President, CFO | Option Exercise | 3,594 | $51.87 | $186.4K | C-Suite |
| Dec 12, 2025 | Norwalk Leslie V | Executive | Sale | 4,000 | $88.85 | $355.4K | |
| Dec 8, 2025 | C. Paul David | Executive | Option Exercise | 34,375 | $25.52 | $877.3K | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 183 | $472.5M | 84.4% |
Exercise(M) | 134 | $87.0M | 15.5% |
Purchase(P) | 3 | $99.8K | 0.0% |
Award(A) | 14 | $0 | 0.0% |
Gift(G) | 18 | $0 | 0.0% |
Conversion(C) | 18 | $0 | 0.0% |
Other(J) | 5 | $0 | 0.0% |
Insider selling pressure at GLOBUS MEDICAL INC has increased, with 26 insiders executing 375 transactions across all time. Total sales of $472.5M significantly outpace purchases of $99.8K, resulting in a net outflow of $472.4M. This selling activity appears largely discretionary, which may warrant closer attention from investors.